Annals of Oncology




One-year access to more than 500 world journals available in the system
    http://medilib.ir
  • Duration of Time : 365 Day
  • Price : 300$
  • Special Price : 100$
Order

Table of Contents

doi : 10.1016/S0923-7534(24)00061-9

Volume 35, Issue 4, April 2024, Pages i-ii

Buy The Package and View The Article Online


Editorial Board

doi : 10.1016/S0923-7534(24)00062-0

Volume 35, Issue 4, April 2024, Page iii

Buy The Package and View The Article Online


Does ‘B’ stand for ‘benefit’? Decoding the B-cell neighborhood in head and neck cancer for predicting therapeutic response to PD-1 inhibitors

doi : 10.1016/j.annonc.2024.01.010

Volume 35, Issue 4, April 2024, Pages 335-337

Buy The Package and View The Article Online


Centralisation of care improves overall survival for sarcoma patients

doi : 10.1016/j.annonc.2024.01.009

Volume 35, Issue 4, April 2024, Pages 338-339

Buy The Package and View The Article Online


B-cell infiltration is associated with survival outcomes following programmed cell death protein 1 inhibition in head and neck squamous cell carcinoma

doi : 10.1016/j.annonc.2023.12.011

Volume 35, Issue 4, April 2024, Pages 340-350

Buy The Package and View The Article Online


Improved nationwide survival of sarcoma patients with a network of reference centers

doi : 10.1016/j.annonc.2024.01.001

Volume 35, Issue 4, April 2024, Pages 351-363

Buy The Package and View The Article Online


Longitudinal profiling identifies co-occurring BRCA1/2 reversions, TP53BP1, RIF1 and PAXIP1 mutations in PARP inhibitor-resistant advanced breast cancer

doi : 10.1016/j.annonc.2024.01.003

Volume 35, Issue 4, April 2024, Pages 364-380

Buy The Package and View The Article Online


Nivolumab in sorafenib-naive and sorafenib-experienced patients with advanced hepatocellular carcinoma: 5-year follow-up from CheckMate 040☆

doi : 10.1016/j.annonc.2023.12.008

Volume 35, Issue 4, April 2024, Pages 381-391

Buy The Package and View The Article Online


TROPHY-U-01, a phase II open-label study of sacituzumab govitecan in patients with metastatic urothelial carcinoma progressing after platinum-based chemotherapy and checkpoint inhibitors: updated safety and efficacy outcomes

doi : 10.1016/j.annonc.2024.01.002

Volume 35, Issue 4, April 2024, Pages 392-401

Buy The Package and View The Article Online


Inflammatory bowel disease and risk of malignant neoplasm in the small bowel

doi : 10.1016/j.annonc.2023.12.012

Volume 35, Issue 4, April 2024, Pages 402-404

Buy The Package and View The Article Online


Current strategies of cell and gene therapy for solid tumors: results of the joint international ESMO and CTIWP-EBMT survey

doi : 10.1016/j.annonc.2023.12.009

Volume 35, Issue 4, April 2024, Pages 404-406

Buy The Package and View The Article Online


Do you want to add Medilib to your home screen?